In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.
World Health Organization - WHO
Brigham and Women's Hospital, Division of Global Health Equity
[Please forward widely & excuse cross-posting] Call to action: Accelerate access to DR-TB drugs Médecins Sans Frontières (MSF), RESULTS UK, SWIFT, Treatment Action Campaign (TAC), Treatment Action Group (TAG) and others are calling on global health actors…
Lancet Infectious Disease just published an interesting opinion piece on what can be learned after the four recent negative trials on the use of fluoroquinolone containing regimens to shorten TB treatment. I have attached that piece to this post. The…
Please find below a letter from MSF regarding the 1st EU Ministerial Meeting on TB and drug-resistant TB (DR-TB) taking place 30-31 March in Riga, Latvia, and the need for improving DR-TB management and R&D. You can download MSF's letter here:…
United Arab Emirates
Cambodia; China; Myanmar; Papua New Guinea; Thailand